Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting

Authors

Rajesh Naidu Janapala, The George Washington University School of Medicine and Health Sciences
Jigar Patel, The George Washington University School of Medicine and Health Sciences
Omar Belfaqeeh, The George Washington University School of Medicine and Health Sciences
Ali Pourmand, The George Washington University School of Medicine and Health Sciences

Document Type

Letter to the Editor

Publication Date

1-1-2021

Journal

International Immunopharmacology

DOI

10.1016/j.intimp.2021.107878

Keywords

HCQ; Hospitalization; Hydroxychloroquine; Mild COVID-19; Mortality

Abstract

We appreciate the efforts of the authors in their study on the clinical outcome of hydroxychloroquine (HCQ) therapy in mild coronavirus disease 2019 (COVID-19) (Mokhtari et al., 2021). We would like to make some comments based on our understanding of the study.

APA Citation

Janapala, R., Patel, J., Belfaqeeh, O., & Pourmand, A. (2021). Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting. International Immunopharmacology, (). http://dx.doi.org/10.1016/j.intimp.2021.107878